Updated Jan. 11, 2024 12:47 pm ET Novartis has backed away from its pursuit of Cytokinetics,…
Tag: Novartis
WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics
Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as pharmaceutical…
Big Pharma’s Battle With the Biden Administration Could Have Legs
Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the…
Europe Is Hit by Shortages of Antibiotics
Rising demand and supply-chain issues are causing shortages of critical drugs for manufacturers.
Novartis to Spin Off, List Sandoz Drugs Business
Novartis is planning to spin off its generics-and-biosimilars division Sandoz and list it as a stand-alone…
Drugmakers Hope New Heart Drugs Boost Sales, Revive Market
The once lucrative heart-drug market is now poised to make a comeback, but at the cost…
Novartis will cut 8,000 jobs worldwide
Swiss pharmaceutical giant Novartis said it plans to lay off 8,000 jobs globally, including 1,400 in…